申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP1679309A1
公开(公告)日:2006-07-12
The compound represented by formula (I)
(wherein ringA is cyclic group which may have a substituent(s), Q is alkyl which may have a substituent(s) or cyclic ring which may have a substituent(s), ringD is cyclic ring which may have a substituent(s), W is a single bond or a spacer of which main chain has an atom number of 1-4, Y is a spacer of which main chain has an atom number of 1-4.), a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof Since the compounds represented by formula (I), a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof have the affinity to MBR, they are useful for the prevention and/or treatment for disease caused by stress.
式 (I) 所代表的化合物
(其中,环 A 为可带取代基的环状基团,Q 为可带取代基的烷基或可带取代基的环状环,环 D 为可带取代基的环状环,W 为单键或主链原子序数为 1-4 的间隔键,Y 为主链原子序数为 1-4 的间隔键)、其盐、其 N-氧化物或其溶液或其原药。由于式 (I) 所代表的化合物、其盐、其 N-氧化物或其溶解物或其原药具有与 MBR 的亲和力,因此可用于预防和/或治疗由压力引起的疾病。